The Digital Medicine & Medtech Showcase, produced by Demy-Colton and EBD Group, is the dedicated home for the digital health and medtech communities during Biotech Showcase™ and one of the healthcare industry’s biggest weeks. Taking place January 13–15, 2020 at the Parc 55 San Francisco – A Hilton Hotel near Union Square, Digital Medicine & Medtech Showcase includes three days of networking opportunities, curated presentations and specialized sessions. These program elements create a forum for innovative digital medicine and medtech companies to plan for successful partnerships and evaluate growth prospects in a shifting healthcare market.
Attendees are able to schedule one-to-one meetings using partneringONE®, and have full access to Biotech Showcase, which meets at the venue across the street, the Hilton San Francisco – Union Square.
Running with concurrent access to Biotech Showcase means the opportunity to participate in meetings among 3,700+ attendees, network with over 1,000 investors, and see 400+ company presentations. At Digital Medicine & Medtech Showcase, there are over 70 dedicated company presentations and 500+ attendees exclusively from the digital medicine and medtech sectors.
One-to-one meeting scheduling opens November 25, powered by EBD Group’s industry-leading platform, partneringONE®. With recently added features, such as enhanced search and a fully-responsive mobile app, partneringONE provides a golden opportunity to find and negotiate asset deals and strategic collaborations.
As part of Digital Medicine and Medtech Showcase, Go to Market LIVE! is a special panel running on Tuesday, January 14 from 4:00–5:00 pm. This interactive pitch session will illustrate what a company must consider from concept to commercialization. One company will receive the opportunity to present to a panel of coaches and receive feedback in front of an audience of over 100 attendees. Qualifying companies can apply here to be considered for the panel. Five runners up will receive a complimentary exhibit space and conference registration. The deadline to apply is November 15, 2019. Apply here now.
The program also includes high-level panels with industry experts sharing their knowledge and insights, such as:
- The New Innovators: Companies at the cutting edge of healthcare
- The Internet of Medical Things: The future of healthcare and the medtech industry
- Pharma and tech’s approach to digital technologies
- Securing reimbursement and its influence on development, investment and market adoption
- Regulating at the speed of technology
- Addressing healthcare deserts with digital tools
- How are investors placing their bets on digital medicine?
Speakers just added to the program include:
- Rubal Bedi – VP and Global Head, Venture Capital, HOYA
- David Kim – Managing Director, digiTx Partners
- Juan-Pablo Mas – Partner, Action Potential Venture Capital
- Beth Rogozinski – CEO, Signal 2 Health
- Rachel Sha – VP, Digital Business Development, Sanofi
- Fred Toney – CEO and Co-Founder, Launchpad Digital Health
Download the event brochure for further information on the agenda, speakers, presenting companies, and one-to-one meeting scheduling.
Event attendees may also get a highly discounted registration to China Showcase, taking place Sunday, January 12, 2020, also at the Parc 55.
Register here for Digital Medicine & Medtech Showcase 2020.
About EBD Group
EBD Group’s overriding mission is to help collaborations get started across the life sciences value chain. Our range of partnering conferences has grown to become the largest and most productive conference platform in the industry. Each one of our landmark events held in key life sciences markets around the world is powered by our state-of-the-art partnering software, partneringONE®, that enables delegates to efficiently identify and engage with new opportunities via one-to-one meetings.
Today our events (BIO-Europe®, BIO-Europe Spring®, BioPharm America™, Biotech Showcase™, China Showcase, Digital Medicine & Medtech Showcase, ChinaBio® Partnering Forum, Rare Disease Innovation and Partnering Summit, and BioEquity Europe) annually attract more than 15,000 senior life sciences executives who engage in over 50,000 one-to-one partnering meetings. These vital one-to-one engagements are the wellspring of deals that drive innovation in our industry.
Tune into EBD Group’s Partnering Insight for timely coverage of news that influences the business strategies of the life sciences industry. Please visit www.ebdgroup.com.
About Demy-Colton
Whether through focused networking conferences or exclusive events, connecting leaders of innovative biotech companies with investors, potential collaborators and key stakeholders is at the core of what we do. It’s our mission to generate genuine enthusiasm about promising biotechnology companies, examine and address the opportunities and challenges facing the biopharmaceutical industry.
From its inception, Demy-Colton has been committed to understanding the complexities and strategic challenges facing the biopharmaceutical industry. Our highly-targeted events and dedication to peer-to-peer exposure foster the growth of next-wave biotech leaders. By carefully targeting and selecting attendees, we ensure more meaningful networking relationships and potential collaborations.
Events include Biotech Showcase, Digital Medicine & Medtech Showcase, China Showcase, BioFuture, Biotech CEO Summit Europe, and Biotech CEO Summit Napa. Since 2008, Demy-Colton has a proven track record of bringing together c-suite management, key advisors and stakeholders to explore mutually beneficial opportunities in the biotech sector. Please visit https://demy-colton.com/.
